title: A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
abstract: BACKGROUND
  Blue light sources have been shown to be effective in the treatment of mild to moderate inflammatory acne vulgaris lesions.
  
  
  OBJECTIVE
  We evaluated the safety and efficacy of a new blue light source in the treatment of mild to moderate inflammatory acne vulgaris in comparison to topical 1% clindamycin solution.
  
  
  RESULTS
  Blue light therapy reduced inflammatory acne vulgaris lesions by an average of 34%, as compared to 14% for topical 1% clindamycin solution.
  
  
  CONCLUSIONS
  The blue light source presented in this report is a safe and effective treatment option available to our patients with mild to moderate inflammatory acne lesions.
authors.affiliation: Gold Skin Care Center, Tennessee Clinical Research Center Nashville, TN 37215, USA. drgold@goldskincare.com
authors.forename: Michael H
authors.initials: MH
authors.lastname: Gold
authors.forename: Jaggi
authors.initials: J
authors.lastname: Rao
authors.forename: Mitchel P
authors.initials: MP
authors.lastname: Goldman
authors.forename: Tancy M
authors.initials: TM
authors.lastname: Bridges
authors.forename: Virginia L
authors.initials: VL
authors.lastname: Bradshaw
authors.forename: Molly M
authors.initials: MM
authors.lastname: Boring
authors.forename: April N
authors.initials: AN
authors.lastname: Guider
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy* / Q000628:therapy*; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019999:Pharmaceutical Solutions; D010778:Photochemotherapy; D010865:Pilot Projects
chemical_list: D000900:Anti-Bacterial Agents; D019999:Pharmaceutical Solutions; D002981:Clindamycin